Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
Abstract |
The original version of this article unfortunately contained a mistake.
|
Authors | Alejandra González-Duarte, John L Berk, Dianna Quan, Michelle L Mauermann, Hartmut H Schmidt, Michael Polydefkis, Márcia Waddington-Cruz, Mitsuharu Ueda, Isabel M Conceição, Arnt V Kristen, Teresa Coelho, Cécile A Cauquil, Céline Tard, Madeline Merkel, Emre Aldinc, Jihong Chen, Marianne T Sweetser, Jing Jing Wang, David Adams |
Journal | Journal of neurology
(J Neurol)
Vol. 267
Issue 3
Pg. 713-714
(Mar 2020)
ISSN: 1432-1459 [Electronic] Germany |
PMID | 32030522
(Publication Type: Published Erratum)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|